Businesses today are navigating unprecedented challenges due to rapid shifts in the global economic landscape and mounting disruptions from trade tensions. Although taxpayers are making good-faith efforts to comply with regulations across jurisdictions, the increasing complexity of legal and policy frameworks has heightened uncertainty and exposure to risk.
This year’s recommendations focus on practical solutions for offshore trust compliance, modernizing transfer pricing procedures, and enhancing Taiwan’s competitiveness for global talent. The Committee urges the tax authorities to adopt more flexible and pragmatic approaches to tax compliance. Such measures would enhance taxpayer confidence, encourage compliance with domestic regulations, and foster a more business-friendly environment, laying a stronger foundation for sustaining growth amid heightened economic uncertainty.
Suggestion 1: Extend the deadline and waive penalties for offshore trust tax reporting obligations.
To support the implementation of Taiwan’s Controlled Foreign Corporation (CFC) rules, the Ministry of Finance issued a ruling in July 2024 requiring offshore trustees to report trust income based on the financials of a Taiwan CFC if the trust property includes shares or capital of the CFC held by a Taiwan settlor. The ruling applies retrospectively from 2024, with the first filing deadline set for February 5, 2025. Failure to file by the deadline may result in tax penalties.
Given the retrospective nature of the rule, the complexity of trust structures, and the time required for information gathering and coordination with offshore trustees, the Committee recommends extending the initial reporting deadline and waiving penalties for trust income filings involving Taiwan CFCs related to the 2024 fiscal year. Doing so would provide affected taxpayers with sufficient time to meet compliance requirements and support a smoother transition to the new reporting regime.
Under the new ruling, offshore trustees are required to submit detailed financial information, including books of account, income statements, distribution records, and other documentation, for all trust assets, including both CFC and non-CFC holdings, in accordance with Taiwan’s Income Tax Act. However, fulfilling these obligations may present considerable challenges for foreign trusts due to the following concerns:
- In many jurisdictions, trustees are bound by strict confidentiality obligations under local trust laws and international practice. Disclosure of trust-related information is generally permitted only with the consent of the settlor or as required by local authorities. Unauthorized disclosure may constitute a breach of fiduciary duty and violate contractual obligations. It remains uncertain whether Taiwan’s ruling can be enforced against offshore trustees or whether the required disclosures are legally permissible under the laws governing the trustee’s jurisdiction.
- In some cases, beneficiaries may be unaware of their status under the trust. Disclosure may require explicit consent from both the settlor and the beneficiaries, particularly where the legality of such disclosure under local laws is unclear. These challenges create significant barriers to compliance and may conflict with legal norms in jurisdictions where the offshore trustees are domiciled.
The Committee therefore urges the government to take the following measures:
- Extend the reporting deadline. Obtaining consent from settlors and beneficiaries may require considerable time, particularly when beneficiaries are unaware of their status or are located across multiple jurisdictions. Extending the reporting deadline would provide offshore trustees with a more reasonable timeframe to secure the necessary consents and fulfill their obligations in compliance with both Taiwan’s requirements and the applicable legal frameworks of other jurisdictions.
- Reconsider penalty liability. As trustees act solely as intermediaries and are not the beneficial owners of trust property, it would be more appropriate for any penalties related to trust income reporting to fall on the settlors or beneficiaries. To encourage cooperation from offshore trustees while respecting their fiduciary obligations and legal limitations, the Committee recommends that trustees serve primarily as information conduits. Penalty liability should rest with the parties ultimately benefiting from the trust, thereby supporting compliance without placing undue burden on trustees.
- Permit the use of alternative accounting standards. As CFCs are typically organized under foreign jurisdictions, preparing financial reports under the Taiwan Generally Accepted Accounting Principles may impose undue burden. Allowing financials to be submitted based on International Financial Reporting Standards or other widely accepted international accounting standards would help reduce compliance costs, thereby enhancing offshore trustee willingness to comply and ensure timely reporting.
Neighboring Asian countries such as Singapore and Hong Kong do not request offshore trustees to comply with the foregoing reporting requirements. Adopting these suggestions would represent a constructive step forward for all parties involved, helping to preserve essential elements of flexibility and confidentiality in succession planning while also supporting compliance with Taiwan’s evolving tax framework.
Suggestion 2: Streamline Customs’ review of one-time transfer pricing applications.
To reduce compliance uncertainty and align with international best practices, the Committee recommends that Taiwan Customs streamline its review process for one-time transfer pricing (TP) applications. Specifically, the approach should be harmonized with globally accepted TP principles and the OECD Transfer Pricing Guidelines to establish a more consistent, transparent, and predictable review framework. Doing so will facilitate cross-border transactions, reduce administrative burdens, and enhance Taiwan’s overall trade competitiveness.
- Allow flexibility in Customs’ coding requirements for one-time TP adjustments. Under tax ruling No. 10804629000 and under the “Operation Directions Governing Customs Value Determination of One-Time Transfer Pricing in a Fiscal Year” (the Directions), importers applying for one-time transfer pricing adjustments (TPAs) are required to follow specific procedural steps. The Directions mandate that the importer of record (IOR) include designated codes and statements on each import declaration to identify shipments eligible for one-time TPA treatment. These include:
.Code 138 in the “Related to Seller” field, which indicates that the buyer and seller are related parties and that the importer is applying for Customs value assessment under one-time TPAs during the fiscal year.
.Code 65 in the “Code of Duty Payment” field, denoting that duty is estimated in advance.
.A remark in the “Other Declarations Particulars” field stating the declaration is “subject to one-time TPA for FYXX.”Import declarations lacking these specific codes or notations at the time of importation are ineligible for consideration under the one-time TPA procedure. This strict procedural requirement may create operational challenges for importers seeking flexibility and alignment with post-importation transfer pricing adjustments.
According to the guidance record form released by the Customs Administration, if the IOR flags only a portion of its import declarations for one-time TPA while leaving others unmarked, and if the pricing of the flagged declarations appears abnormally high, suggesting a concentration of annual profits, Customs may view the application as non-compliant and reject the proposed adjustments. These constraints create additional complexity and uncertainty for taxpayers, particularly in situations where the need for TPAs is identified only after year-end financial reviews. - Address practical challenges in implementing one-time TPAs under current Customs procedures. Due to the unpredictable nature of year-end TPAs, multinational corporations (MNCs) often cannot determine whether such an adjustment is necessary until after financial results become available, typically at the end of the fiscal year or after a material period has passed. As a result, by the time an MNC identifies the need for a TPA, most related import declarations may no longer be eligible for the one-time TPA application due to procedural requirements. This presents a particular challenge for a Taiwan-based IOR, who at the time of importation is often unaware whether a TPA will be required or which specific shipments should be flagged in advance.
According to the guidance form issued by the Customs Administration, one-time TPAs may only be applied to import declarations that were pre-identified for one-time TPA treatment using codes such as 138, 65, and fiscal-year-specific wording. However, because many companies only determine the need for a year-end TPA after reviewing mid- or late-year financial outcomes, earlier shipments are often not flagged in advance. As a result, otherwise eligible adjustments may be disallowed, limiting the Taiwan IOR’s ability to accurately reflect the economic value of the goods and creating unnecessary compliance uncertainty.
This procedural rigidity gives rise to several critical issues:.Misalignment with international best practices. The current requirements diverge from the principles advocated by the World Customs Organization (WCO) and the World Trade Organization, both of which advocate for more practical alignment between transfer pricing policies and customs valuation practices in related-party transactions. For example, the WCO’s 2018 Guide to Customs Valuation and Transfer Pricing encourages Customs administrations to adopt a substance-over-form approach, particularly in evaluating post-import TPAs. The guide notes that strict procedural barriers may undermine the accurate reflection of the transaction’s economic value and recommends practical flexibility in documentation and timing.
.Disconnect between declared and actual transaction value. A strict requirement to pre-flag eligible import declarations may result in a significant discrepancy between the customs value declared at the time of importation and the final, transfer price-adjusted transaction value, undermining accuracy in customs valuation.
.Increased administrative and audit burden. Customs is tasked with reconciling the full TPA amount against only those shipments pre-identified for one-time TPA treatment.To address these challenges and align with international practices, the Committee recommends that Customs relax its current review framework by allowing one-time TPA applications to be evaluated based on the substance of the transfer pricing arrangement, rather than limiting eligibility to declarations flagged with code 138, code 65, and fiscal year-specific wording. A principles-based approach would ease administrative burdens for both Customs and importers and offer greater regulatory flexibility.
Alternatively, if immediate implementation is not feasible, the Committee suggests permitting retroactive corrections to import declarations to add the required codes and wording. While current policy limits corrections to obvious errors, expanding this scope would offer a practical solution for compliant importers who identify the need for a TPA after importation. This would support policy goals of accuracy, transparency, and trade facilitation without compromising procedural integrity.
Suggestion 3: Ensure continuity of tax incentives for qualified foreign talent.
According to the National Development Council, over 12,000 Employment Gold Cards have been issued since the program’s launch. However, anecdotal feedback indicates that the loss of tax benefits following a job change has contributed to early departures among qualified professionals.
Under current policy, foreign professionals holding an Employment Gold Card or a Foreign Special Professional Visa lose their tax benefits if they change employers, even if they remain within the original five-year eligibility window. In addition, individuals who initially held a standard Alien Resident Certificate (ARC) and later transitioned to an Employment Gold Card or Foreign Special Professional Visa are often excluded from the incentive program, despite otherwise meeting the required criteria.
The Committee encourages the tax authorities to allow eligible Gold Card and Foreign Special Professional Visa holders to retain their tax benefits throughout the full five-year period, regardless of job changes or earlier visa status. This adjustment would align Taiwan more closely with countries like Singapore, which offers tax incentives for up to five years based on continued contribution to strategic sectors.
Many foreign professionals may opt to leave Taiwan once their tax benefits expire. To improve talent retention and support economic growth, we urge the government to consider extending tax benefits for long-term foreign residents who continue to contribute meaningfully to the local economy. Removing penalties for career mobility or residency upgrades would help Taiwan remain competitive in attracting and retaining global talent.
鑒於全球經濟格局快速變化,且貿易緊張局勢導致干預日益加劇,企業正面臨前所未有的挑戰。儘管納稅義務人致力遵循各租稅管轄區的法規,但法律和政策框架日益複雜仍增加了不確定性和風險。
我們今年的建議著重於解決境外信託實務上遵循的困難、移轉訂價程序的現代化以及增強台灣對全球人才的競爭力。我們呼籲稅務機關採取更有彈性和務實的方法促進稅務合規,以增強納稅義務人信心、鼓勵遵循台灣當地法規,並營造更友善的經商環境,在經濟不確定性加劇的情況下奠定更堅實的基礎以持續成長。
建議一:延長境外信託受託人申報截止日期並豁免相關罰則
為因應台灣受控外國公司(Controlled Foreign Corporation, CFC)制度的實施,財政部於2024年7月發布新函令規範,台灣委託人若以其持有的台灣受控外國公司股份或資本作為信託財產,則境外受託人有義務就受控外國公司財務狀況申報信託收益資訊。該函令追溯至2024年起適用,第一年提交申報資訊截止日期為2025年2月5日,未能在截止日期前提交之受託人可能會面臨稅務罰則。
考量該法規為追溯適用、信託結構的複雜性以及蒐集資訊和與境外受託人協調所需的時間,本委員會建議延長首年度申報截止日期並免除2024年度相關的申報罰則。如此一來,納稅義務人較有充足的時間遵循相關規定,並有助於過渡期間順利適用新的申報規定。
根據新頒函令,境外受託人必須依據台灣《所得稅法》提供信託資產詳盡的財務資訊(包括帳簿、損益表、盈餘分配報表和其他相關文件)。然而,基於以下眾多挑戰,境外信託可能難以滿足前述申報要求。
- 於眾多轄區,受託人受到當地法令和國際慣例之拘束,對與信託相關的資訊負有嚴格的保密義務。僅在特定情況下,例如經委託人同意或依當地政府要求,方得揭露相關資訊。未經授權而揭露可能將被視為違反受託人責任及合約義務。此函令是否可針對境外受託人強制執行加以適用及施行,或者受境外受託人所在轄區之法律下所允許仍有待商榷。
- 申報要求揭露受益人資訊亦引發額外的擔憂。於某些情況下,受益人可能並不知情其為信託關係下之受益人。然而,特別是在前述要求揭露受益人的申報規定在當地法律是否合規尚不明確之情形下,因揭露可能需要委託人及受益人的明示同意,這些挑戰為合規帶來重大障礙,並且可能與境外受託人所在轄區的法律規範有所衝突。
因此,本委員會建議政府採取以下措施:
- 延長申報截止日期:當受益人對其信託關係並不知情或受益人位於數個不同轄區時,取得委託人和受益人的同意可能需要相當長的一段時間,延長申報截止日期將為境外受託人提供更合理的時間範圍,以取得必要的同意並確保能按照台灣的要求和其他轄區的適用法律履行其義務。
- 重新衡量罰款責任:由於受託人僅為委託人和受益人之間的中介,而非信託財產之受益人,故由委託人或受益人承擔因申報責任所產生的任何罰款較為合理。為鼓勵境外受託人遵循,並尊重其信託義務和法律限制,本委員會建議受託人主要擔任資訊溝通管道,而罰則則應由信託最終受益方承擔,以符合法遵且不致加諸過度負擔予受託人。
- 允許使用替代會計準則:由於受控外國公司通常位於境外轄區,因此根據台灣一般公認會計原則編製財務報表可能會對該等公司造成過度負擔。若允許其根據國際財務報導準則或其他已被廣泛接受的國際財務準則申報信託財產財務數據,則可降低遵循成本、提升申報意願並確保期限內完成申報。
新加坡和香港等亞洲鄰國並未針對境外受託人有上述申報要求。採納前述建議將為各方邁出建設性的一步,有助於保持信託繼承規劃所必要的靈活度和保密性,同時支持遵循台灣不斷演進的稅務框架。
建議二:放寬目前海關針對一次性移轉訂價核定完稅價格作業的審核方式
本委員會建議放寬目前海關針對一次性移轉訂價(TP)核定完稅價格作業的審核方式,以調和海關估價與移轉訂價概念,符合全球公認的TP原則及OECD移轉訂價指導原則,以更接近國際貿易環境並減少法遵的不確定性。建立一致、透明且可預測的審查架構將有助於跨境交易,減少行政負擔,並提升台灣整體貿易競爭力。
- 允許一次性移轉訂價調整之進口報單標註代碼要求的彈性
根據台財稅字第10804629000 號函及《海關實施會計年度一次性移轉訂價核定完稅價格作業要點》(下稱《作業要點》),欲申請一次性移轉訂價調整(TPA)的進口人應遵循特定程序。依《作業要點》規範,進口人應於欲申請一次性移轉訂價調整之進口報單上標明特定代碼以及相關註記,包含:.代碼「138」:於特殊關係欄位填報,表示「有特殊關係,辦理會計年度一次性移轉訂價核定完稅價格案件」;
.代碼「65」:於納稅辦法欄位填報,表示「預估稅捐」;以及
.於其他申報事項欄位註記「辦理○○○會計年度一次性移轉訂價作業與其適用之會計年度期間」。而倘若進口當下,進口人並無於進口報單上標明特定代碼以及相關註記,則不符合一次性移轉訂價調整申請條件。這項嚴格的程序要求可能會帶來實務操作上的挑戰,因該申報不容許誤植或進口後更正資訊,而限制進口業者於會計年度結束後施行一次性移轉訂價調整之彈性。
根據關務署發佈的《海關實施會計年度一次性移轉訂價核定完稅價格作業政令宣導紀錄表》(下稱《宣導記錄表》),營利事業申請一次性移轉訂價作業,須考量調整後之正式價格是否涵蓋全部成本及利潤,應避免僅少數報單註記一次性移轉訂價,而於會計年度結算時將全年度利潤集中於少數報單調整致該等報單貨物出現極端價格情形,倘發生是類情事,海關將視為未符合規定而不接受營利事業調整內容。這樣的結果,特別是對於只有在年終財務審計時後才發現需要進行移轉訂價調整的納稅義務人而言,將為其帶來額外的複雜性和不確定性。 - 解決當前海關環境下企業申請一次性移轉訂價調整之實務挑戰
由於移轉訂價調整之本質上是無法預期的,跨國企業通常僅能在會計年度結束前或年度過了一段時間後有一定的財務結果,才能評估是否需要進行移轉訂價調整。因此當跨國企業經評估該年度經營狀況,真正決定需要進行移轉訂價調整時,通常會面臨因大多數進口報單不符前述標註特定代碼以及相關註記之程序要求,而無法申請一次性移轉訂價調整之情況。換言之,臺灣進口人於適用一次性移轉訂價核定完稅價格之挑戰在於,進口人於貨物進口當下通常無法確認公司該年度是否需進行移轉訂價調整,或應於哪些進口報單上進行標註,以聲明欲申請一次性移轉訂價調整。
根據《宣導記錄表》,移轉訂價調整適用於進口當下有相關一次性移轉訂價調整註記(即代碼「138」、「65」與註明會計年度相關文字註記)的進口報單。然而,企業往往需至會計年度中後期檢視財務結果後,方能確定是否需要進行一次性移轉訂價調整,因此該會計年度較早填報之進口報單多未預先註記。此舉可能導致企業的一次性移轉訂價調整因而無法獲准,致使臺灣進口人無法精確反映進口貨物交易之經濟實質,亦增加不必要之法遵不確定性。此種僵化之行政程序也衍生出以下關鍵問題:.與國際最佳實務做法不一致:臺灣現行做法與世界關務組織(WCO)及世界貿易組織(WTO)的立場不一致,該等組織主張實務上調和移轉訂價調整政策與海關估價方式,為關係人交易建立可行之解決方案。例如,世界海關組織(WCO)於2018年發布的《海關估價和移轉訂價指南》中鼓勵海關採用實質重於形式的做法,尤其是在評估貨物進口後之移轉訂價調整方面。該指南指出,嚴格的行政程序可能會無法準確反映交易的經濟實質,並建議於申請文件和時程上保留彈性。
.申報價格與實際完稅價格不同:嚴格要求預先標註申請一次性移轉訂價之相關註記,可能會導致貨物的完稅價格與最終經一次性移轉訂價調整的實際/最終的貨物交易價值間存在重大差異,從而削弱海關估價的準確性。
.海關行政及審核負擔增加:現行海關核估一次性移轉訂價之完稅價格時,需將移轉訂價調整金額分配並調節至已標註申請一次性移轉訂價之進口報單上各項次貨物單價上進行核定。為解決當前挑戰及符合國際實務操作,本委員會建議放寬目前海關對一次性移轉訂價調整的審核機制,建議不僅限於將移轉訂價調整金額分配於已標註申請一次性移轉訂價調整(註記代碼「138」、「65」與註明會計年度相關文字)的進口報單中,而應採用基於移轉訂價安排的實質性進行申請案之審核。以此概念為基礎的審核作業將可減輕海關與進口人的行政負擔,並提升監管靈活性。
如上述方法難以實施,考量現行海關更正進口報單之法規和實務,目前進口人僅能就報單中之顯然錯誤進行更正,本委員會建議可考慮放寬當前更正報單規範,允許進口人針對進口報單特定代碼以及相關註記欄位進行更正,此舉將有助於減少進口人於貨物進口後,因進口報單不符特定註記程序要求,而無法適用一次性移轉訂價核定完稅價格之情況,也將在不妨礙程序完整性的情形下,支持政府實現準確、透明及提升貿易便捷化的政策目標。
建議三:確保國際人才在持有就業金卡和特殊專業人才簽證期間完整享有稅務優惠
依據國家發展委員會統計,自推出「就業金卡」以來,已核發超過12,000張就業金卡。然而,據悉因轉換工作而失去稅務優惠是導致外國專業人才提前離職的考量之一。
在現行政策下,即使外國專業人才所持就業金卡或特殊專業人才簽證仍在五年的優惠期限內,若更換工作,仍將失去其原享有之稅務優惠。另原持有一般居留證(ARC)者,若改持有金卡或特殊專業簽證並符合相關條件,亦仍無法享受相關稅務優惠。
本委員會呼籲稅務機關,准許所有就業金卡和特殊專業人才簽證持有者,不論其工作變動或先前持有簽證型態,均能在持有金卡及該簽證的完整五年內享有稅務優惠,使台灣能接軌其他國家提供外國專業人才之稅務優惠(例如新加坡評估對關鍵產業的貢獻而提供至多五年稅務優惠)。
有鑑於外國專業人才恐因稅務優惠到期而選擇離開台灣,本委員會建議政府考慮針對有意長期留在台灣發展與貢獻的外國專業人才延長其稅務優惠,以提升人才留任率並持續強化台灣經濟。外國專業人才不應因追求更好的工作機會或升級簽證身份而受到失去稅務優惠的懲罰,確保其享有金卡及簽證完整期間之稅務優惠,將有助於維持台灣在吸引及留任全球人才的競爭力。
The Committee is grateful to the Taiwan Food and Drug Administration (TFDA), Ministry of Health and Welfare (MOHW), and Ministry of Agriculture (MOA) for their recognition of and support for our previous suggestions. To effectively address climate change and maintain food security, we urge the authorities to consider our latest suggestions and continue to improve relevant management policies in accelerating the introduction of new pesticide products that are highly safe, efficient, and low-intensity, as well as new technologies for promoting breeding innovation. Doing so will help reduce environmental harm and enable agricultural sustainability. Further, we urge the MOA to accelerate the revision schedule for the Agro-pesticides Management Act.
Suggestion 1: Accelerate revision of Article 14 of the Agro-pesticides Management Act and related labeling regulations.
This suggestion has been brought up in every White Paper since 2019, but no progress has occurred. Article 14 of the Act provides that following the MOEA’s approval of changes in a pesticide label, all relevant products must be relabeled within six months. Such a requirement is reasonable for changes potentially affecting the safety of a product. However, if the change has no impact on farmers’ safe use of pesticides, there is no need for a product already on the market to be withdrawn for relabeling.
Following the approval of new labeling, the procedures for either recalling products from the market or replacing labels have become overly complicated and burdensome, leading to significant costs. Moreover, the requirement that labels cannot be updated by merely marking the change, modifying the adhesive label, or affixing a new adhesive label over the old one necessitates that products (such as those in aluminum sacks) be unpacked and then repacked, which in turn raises occupational safety concerns about the repeated exposure of workers to these products during the process.
Further complicating matters are sporadic announcements from the government regarding changes in the use pattern or cautionary notes about individual products, as these necessitate re-approval of the label if any license has been submitted for renewal or amendment. This requirement wastes resources and results in additional costs, including the destruction of existing inventory labels and the labor-intensive process of unpacking and repacking recalled products.
Recommendations:
- Fast-track revisions to Article 14 of the Agro-pesticides Management Act. Since 2019, the Committee has been calling for amendments, such as removal of the mandate to recall products within six months due to minor label amendments that do not affect safety or manufacturing, but has yet to see any substantial action or even receive a formal reply. We urge the Animal and Plant Health Inspection Agency (APHIA) to confirm that our proposed amendment to Article 14 is among the prospective revisions. Furthermore, we urge APHIA to accelerate the drafting process, enabling a bill to be submitted for legislative approval without further delay.
- Add a positive list in the Enforcement Rules of the Agro-pesticides Management Act specifying the types of changes that do not require relabeling. Changes such as the name of the manufacturer, extension of product shelf life, and modifications to packaging, labeling design, and barcodes have no impact on product safety. The practice of allowing such modifications without relabeling is already common in other industries. To avoid unnecessary costs and waste, and in consideration of industry practice, the sale of products should be allowed to continue until their expiry dates.
Suggestion 2: Expedite the review process for new active ingredients and products with new content or new formulations.
Under APHIA’s 10-year plan to reduce the volume of chemical pesticide usage by half, companies are encouraged to register pesticides with high safety, low dosage, and specificity to reduce the risks of pesticide exposure to farmers, as well as to mitigate negative environmental impact. Achieving that goal will require the approval of products with new active ingredients and new formulations.
Whether for pesticide registration, renewal, or re-registration, however, the proportion of application approvals for new active ingredients and new formulation products has been minimal. Statistics compiled by APHIA’s Agricultural Information Network show that of the 229 certificates issued in 2023, only 3 were for new active ingredients. In 2022, 296 certificates were issued, with a mere 9 dedicated to new active ingredients. Additionally, on the list of active ingredients that have passed the 15-year pesticide re-registration, 20 active ingredients were approved in 2023, much fewer than the 34 approved in 2022.
We urge APHIA to prioritize the allocation of its review and administrative capacities toward innovative products, such as those with new active ingredients and new formulations. This prioritization would spur the launch of innovative products and aid the elimination of high-hazard or high-risk formulation products.
Suggestion 3: Accelerate the administrative process for determining the maximum residue limits for pesticides.
We are grateful to the TFDA and the MOHW for their commendable efforts in increasing the frequency of announcements regarding the maximum residue limits (MRLs) of pesticides. The TFDA has consistently issued official announcements on MRLs at least three times annually, a practice that greatly benefits stakeholders by providing clearer regulatory guidance.
Despite these improvements, several aspects of the administrative procedures for pesticide registration remain unclear. These ambiguities have caused delays in the registration process, significantly impacting applicants who have made substantial investments in Taiwan. Uncertainty regarding the following points has made it challenging for applicants to predict the approval timeline for their applications:
- The timeline for sending cases to APHIA to schedule review by the Pesticide Advisory Committee under the MOA after the cases have passed review by the Agricultural Chemicals Research Institute.
- The timeline for sending cases to the TFDA after they have passed the Pesticide Advisory Committee’s review.
- The timeline for arranging document reviews by experts and comprehensive review by the Food Sanitation, Safety and Nutrition Advisory Committee after the TFDA has received a case.
- Following case reviews, the various required administrative procedures and joint actions involving some 20 functional offices or units. These procedures may take more than one month, not including the time required for subsequent pre-notification and official announcement of related regulations, which may take at least another four months.
- APHIA’s informal pre-notification procedure that, although officially optional, is being enforced as if mandatory. Completing this process can take up to two months. APHIA has advised the Committee that applicants are expected to initiate direct communication with the TFDA, requesting that it notify APHIA about the contents of any forthcoming announcement prior to its public disclosure. In practice, this procedure significantly delays APHIA’s ability to announce the approved use pattern of registration after the TFDA discloses the finalized MRLs. This extended timeline for procedural compliance not only complicates the registration process but also affects the timely introduction and use of registered products, hindering the efficient management and implementation of agricultural practices.
- The requirement that companies await an official announcement from APHIA before proceeding with applications for permits or changes in labeling. This administrative procedure alone can take at least one month.
We urge departments within the MOA and the MOHW to establish and clearly define the procedures and precise timings of administrative processes at both the ministerial and departmental levels. Clarifying these procedures would help streamline the administrative process to the benefit of all stakeholders.
Additionally, we ask that these procedural details be made available to the public. Such transparency could significantly enhance horizontal communication across different ministries and departments, leading to a more coordinated and efficient administrative process.
Suggestion 4: Reassess the reasonableness of data requirements for registering generic pesticides to ensure safe and effective use by farmers.
The Committee has raised this issue in the past four White Paper issues, but no progress has been made. Compared to the regulatory frameworks in other countries for registering generic agricultural products, the procedure in Taiwan stands out for its conciseness, requiring only the submission of physical and chemical data. This approach focuses on ensuring that the active ingredients and formulation type of the generic product match those of the originally registered product.
However, other ingredients in the product may differ from what was covered in the original comprehensively evaluated registration. This discrepancy in composition raises concerns about the efficacy of the generic products, as it cannot be guaranteed to fully match that of the original products. As a result, farmers may inadvertently overuse these products or use them in ways that deviate from the government’s pesticide reduction policy.
Recommendations:
- Revise current legislation to mandate at least one field test assessing the efficacy of generic pesticides on the crops for which registration is sought.
- Require the submission of comprehensive toxicological data for the registration of generic products. Data should include reports on oral-, dermal-, and inhalation-acute toxicity, as well as eye irritation tests, to unequivocally demonstrate the safety of the generic products for users.
- Formalize the registration process for generic pesticides. This process should include evaluation by the MOA’s Pesticide Advisory Committee for the generic product’s necessity, efficacy, and safety before approval is granted. Such measures will ensure that generic pesticides introduced into the market meet the expected high standards of performance and safety, thereby protecting users and supporting the goals of pesticide reduction and sustainable agriculture practices.
Suggestion 5: Set up a transparent regulatory frame-work with a predictable timeline and adopt a product-based regulatory approach harmonized with Taiwan’s major trading partners for genome-edited products.
Agricultural innovation has played an essential role in increasing yields and productivity in support of growing, prosperous civilizations. Moreover, considering the rapidly growing world population, climate change, and increasing scarcity of natural resources such as arable land and water, progress in plant propagation has gained unprecedented importance.
High-yielding crops of superior nutritional value that can be grown more resource-efficiently are increasingly becoming the cornerstone of sustainable yet highly productive agriculture. In addition, there is a need to make crops more pest- and disease-resistant as well as more tolerant to adverse conditions such as drought, heat, submergence, and salinity. Innovations in precision biotechnology, such as gene editing, are therefore required to enhance the speed, predictability, precision, and success rate of plant breeding.
As highlighted in the 2023 White Paper, the World Trade Organization released the joint International Statement on Agricultural Applications of Precision Biotechnology, supported by 10 members, urging governments to implement science-based and globally harmonized policies for precision biotechnology. To support agricultural innovation, many of Taiwan’s key trading partners – including Argentina, Australia, Brazil, India, Japan, the Philippines, and the United States – have since implemented well-functioning and proportionate regulatory systems. These markets have exemptions granted certain types of gene-edited crops from their GMO regulations. Furthermore, the exemption by some government agencies can be evaluated and confirmed through a pre-consultation mechanism.
Over the past 12 months, some countries and regions have made further noteworthy progress in developing policies for the management of genome-edited products. For example, the European Commission released its New Genomic Techniques (NGT) proposal for new regulation on plants produced by certain new genomic techniques (for example, gene-editing technology) on July 5, 2023. The Commission also proposed that Category 1 NGT plants should be exempted from the requirements of GMO legislation, affirming the Commission’s position that plants derived from these technologies have safety profiles comparable to conventional counterparts and may contribute to sustainable agriculture and the European Union’s Farm to Fork Strategy, as concluded in the NGT study published on April 29, 2021.
On December 20, 2023, the Singapore Food Agency released a policy document for public consultation on the regulatory framework for genome-edited crops for food and feed. This document proposed that plants that do not contain foreign DNA should be exempted from pre-market safety assessment. On January 18, 2024, Thailand’s Technical Biosafety Committee approved the Guidelines for Consideration of Genome Editing, stipulating that products lacking novel genetic combinations or foreign genetic sequences should be exempt from GMO regulation.
These recent policy developments have demonstrated the importance of precision biotechnology such as gene editing to address challenges in agricultural production as well as to support food sufficiency and achieve sustainability goals.
Taiwan is a key global trading partner for agricultural products, including seed and plant products. To help Taiwan maintain a competitive and secure food and feed supply, we urge the government to establish a transparent regulatory framework with predictable timelines and adopt a product-based regulatory approach for gene-edited products to ensure harmonization with Taiwan’s major trading partners.
農化委員會非常感謝衛生福利部食品藥物管理署及農業部的支持並重視本委員會所提出的建議。為因應氣候變遷及維持糧食安全等需求,祈請各主管機關能考量以下建言,持續精進相關管理政策,以期能加速引進高安全性、高效率且用量少的新型農藥產品及有助育種創新的新技術,得以減少環境危害並促進農業環境永續發展,進一步加快農藥管理法修訂進度。
建議一:加速修訂《農藥管理法》第14條及相關規定
本委員會自2019年起不斷提出本項訴求,迄今未觀察到任何實質性作為。《農藥管理法》第14條第1項及相關子法《農藥標示管理辦法》明列:標示經核准後「原標示應於六個月內更換之」,對於可能影響產品安全性的變更,這樣的要求是合理的;但若不影響農民使用安全之內容,已上市產品則應無需撤回重新貼標。
標示核准變更後,市售產品回收或更換標示程序繁瑣及困難,造成大幅增加額外處理成本。此外,法規明訂「更換之標示,不得以塗改、貼紙修正、重複黏貼方式為之」,部分產品標示需要整個拆除包裝後再重新分裝(例如鋁袋),增加作業人員重複暴露這類產品的職業衛生安全疑慮。
另外,主管機關對於個別產品的登記使用範圍或注意事項等變更的零星公告,導致辦理許可證登記相關事項時,將強制依最新公告內容要求進行標示修正,已造成資源的浪費及額外成本,例如:銷毀已印製之原核准標示、回收及重新分裝市場上尚未銷售完畢之產品等。
【建議 】
- 請加速修訂《農藥管理法》第14條及相關規定。本委員會自2019年起不斷提出進行相關法規修訂,例如:希望取消六個月內召回未符合實際製造工廠或無關安全疑慮之些微標示修改的限制,卻未觀察到任何實質性作為或正式答覆。敦請農業部動植物防疫檢疫署 研議本委員對於該法14條提出之建議內容,加速修訂草案,盡快將其提送至立法院進行審議及批准。
- 建議於農藥標示管理辦法中增訂正面表列以明訂不需進行回收或更換標示事項,例如:變更國外生產工廠、變更標示有效期間、修改包材設計或條碼變更等無關產品安全性等標示變更內容。標示修改後不進行回收並重新標示之作法,已在其他行業類別中行之有年,為避免不必要的資源浪費及成本,並考量產業慣例,應允許前述無關產品使用安全性之樣態,原市售產品標示可允用及販售,直至該批產品效期為止。
建議二:加速新有效成分、新劑型產品之審查登記
因應農業部動植物防疫檢疫署「化學農藥十年減半行動方案」,主管機關鼓勵業者登記安全性高、用量少、具專一性農藥,以降低農民用藥暴露及環境影響風險,建請將主要審查與行政量能投入在於新有效成分、新劑型含量等創新產品,以加速該類產品加速上市以汰換高危害或是高風險之成品農藥。
農藥登記、展延、重新評估,審查類型種類繁多,但主管機關對新有效成分及新劑型產品之審查通過占比相當微量。依農藥資訊服務網公開資訊統計,2023年成品農藥進口證與製造證共發證229張,其中僅3張屬於新有效成分;2022年成品農藥進口證與製造證共發證296張,其中僅9張屬於新有效成分。另外參考登記屆滿15年農藥有效成分審查通過清單,2023年通過20個有效成分,2022年通過34個有效成分。
【建議 】
建請農委會加速對新有效成分、新劑型產品之審查與核可,有助於汰換高風險之產品。
建議三:加速農藥殘留容許量訂定之行政程序
感謝食藥署及衛福部近年已改善農藥殘留容許量標準 (以下簡稱容許量)公告頻度,目前已可觀察到每年至少3次容許量之正式公告,使各相關產業有明確的法源依據而受益匪淺。雖已觀察到公告頻度的改善,但農藥登記的程序中仍有諸多不明確之行政流程,導致延宕產品登記及影響申請人投資意願,以下幾點之不確定性造成申請人難以預測登記的核准時間:
- 案件經農業部農業藥物試驗所審畢後,提送農業部動植物防疫檢疫署(以下簡稱防檢署)進行農藥技術諮議會(以下簡稱農藥諮議會)排程之所需時間。
- 案件審查通過農藥諮議會後提送食藥署之所需時間。
- 案件進入食藥署後安排專家書審及會議審查所需時間。
- 資料審查完畢後,仍須耗費大量行政程序及時間會辦至少20多個組室或單位,耗費1個月以上的時間,且不包括後續預告、公告之法制作業至少4個月的時間。
- 防檢署強制執行非法制程序的「預先通知公告」流程需耗時至少兩個月,先前多次於白皮書中回覆申請人應自行與食藥署溝通,並請食藥署公告前先行副知防檢署該公告作業內容。因此,即使食藥署已公告訂定農藥殘留容許量,此程序已造成防檢署嚴重延遲公告核准使用方法與增加流程複雜性,並影響新產品的及時引進及使用,影響農業生產管理之作業。
- 申請人須待防檢署正式公告後才能辦理後續許可證請領或是進行標示變更等需額外耗費月餘的多項行政作業。
【建議 】
建請農業部及衛生福利部轄下各機關明確訂定部會間及部會內所需之各項行政程序及所需時程並公諸於眾。澄清這些程序將有助於簡化行政流程,使產、官雙方受益;此外,我們希望相關程序可以公開透明化,各部會間可以改善或加強跨部會之橫向溝通,增加協調性及提高行政效率。
建議四:正視農藥學名藥(成品)要求登記的合理性,以確保農民用藥之安全性及有效性
委員會已第四年提出此議題,至今尚未觀察到農藥主管機關對於學名藥成品有任何精進管制作為。
綜觀其他各國之學名藥登記,僅有台灣對於學名藥登記之資料要求最簡要(僅需繳交物理及化學數據資料),這種作法僅確認學名藥有效成分、劑型與原廠藥劑相同。然而,其他成分皆與最初、受充分審查之原廠藥劑不同。這種成分上的差異,引起了藥效以及產品安全上的擔憂,因為配方不能確認與原廠產品完全匹配。因此,易造成農民可能會無意中過度使用這些產品,並悖離農藥減量政策。
故,委員會建議主管機關修法:
- 學名藥應於擬登記作物至少進行一場次藥效藥害田間試驗以利評估藥效
- 學名藥產品須提交毒理報告(口服、皮膚、呼吸急毒性與眼刺激性試驗資料),以證明該學名藥劑之安全性,並維護使用者之安全。
- 委員會也建議,關於學名藥查驗登記,應屬正規登記流程,該正規程序應包括諮議會審議批准之前對其必要性、防治效果及安全性進行評估。此類措施將確保引入市場的學名藥符合預期高標準的藥效以及安全性,從而保護使用者並支持農藥減少和永續農業實踐的目標。
建議五:敦促主管機關針對基因編輯產品建立透明的監管架構和可預期的時程,並採取與貿易夥伴一致、依產品為導向的監管方式
農業創新在提高產量和生產力上發揮了至關重要的作用,進而得以支持日益繁榮的文明。此外,鑑於世界人口的迅速增長、氣候變遷以及可耕地和水等自然資源的日益稀缺,植物育種的進展更是前所未有的重要。產量高、營養價值提升且資源利用效率更佳的作物日漸成為永續又高產量之農業的基石。再者,作物需要更能夠抵抗病蟲害,並對逆境如乾旱、高溫、淹水和鹽害等不利的種植條件更具耐受性。因此,需要基因編輯等精準生物技術之創新來提升植物育種的速度、可預測性、精確性和成功率。
如2023年白皮書中所強調的,世界貿易組織(WTO)於2018年發布由十個會員國共同簽署的《國際精準生物技術農業應用聲明(International Statement on Agricultural Applications of Precision Biotechnology)》,該聲明敦促各國政府實施基於科學且全球調和的精準生物技術相關政策。為了支持農業創新,許多台灣的主要貿易夥伴,包括美國、日本、澳洲、阿根廷、巴西、菲律賓和印度均已經訂定實施運作良好且合宜的監管制度,並將特定類型的基因編輯產品從基因改造的管理範疇中排除。政府主管機關可經由預先諮商的方式,根據產品的特性進行評估,來確認其是否符合豁免範疇。
在過去的12個月中,部分地區和國家對基因編輯產品管理政策制定取得了顯著的進展。舉例來說,歐盟執委會於2023年7月5日發布了新基因體技術(New Genomic Techniques, NGT)提案,對利用新基因體技術(例如基因編輯技術)開發的植物提出新的法規,並提議第一類NGT植物可從基因改造生物法條的要求中豁免排除,據此確認歐盟執委會的立場,認同源自這些技術的植物具有與傳統植物相當的安全性,並且能有助於歐盟主張的「從農場到餐桌策略」和環境永續性,其與2021年4月29日歐盟執委會發布的NGT研究所得到的結論一致。
2023年12月20日,新加坡食品局提出一份政策文件,就食品和飼料用基因編輯作物的監管架構進行公眾諮商,這份文件提議,不含外源DNA的植物可免除上市前的安全評估。此外,2024年1月18日,泰國的技術性生物安全委員會(Technical Biosafety Committee)核准其「基因編輯技術研發生物之評估指引(Guideline for Determination of Organisms Developed by Genome Editing Technology)」,認定不含新穎基因組合或外源基因序列的產品可免除基因改造法規的監管。最近的這些政策發展都證明精準生物技術(如基因編輯)對於解決農業生產挑戰以及支持糧食自給自足和實現永續發展目標的重要性。
台灣身為農產品(包括種子/植物產品)上重要的全球貿易夥伴,為了協助台灣維持競爭力並確保充足的糧食和飼料原料供應,我們敦促食品藥物管理署和農業部能對基因編輯產品建立透明的監管架構和可預期的時程,並採取與台灣主要貿易夥伴一致、依產品為導向的監管方式。
The Committee is grateful to the Taiwan Food and Drug Administration (TFDA), Ministry of Health and Welfare (MOHW), and Ministry of Agriculture (MOA) for their recognition of and support for our previous suggestions. To effectively address climate change and maintain food security, we urge the authorities to consider our latest suggestions and continue to improve relevant management policies in accelerating the introduction of new pesticide products that are highly safe, efficient, and low-intensity, as well as new technologies for promoting breeding innovation. Doing so will help reduce environmental harm and enable agricultural sustainability. Further, we urge the MOA to accelerate the revision schedule for the Agro-pesticides Management Act.
Suggestion 1: Accelerate revision of Article 14 of the Agro-pesticides Management Act and related labeling regulations.
This suggestion has been brought up in every White Paper since 2019, but no progress has occurred. Article 14 of the Act provides that following the MOEA’s approval of changes in a pesticide label, all relevant products must be relabeled within six months. Such a requirement is reasonable for changes potentially affecting the safety of a product. However, if the change has no impact on farmers’ safe use of pesticides, there is no need for a product already on the market to be withdrawn for relabeling.
Following the approval of new labeling, the procedures for either recalling products from the market or replacing labels have become overly complicated and burdensome, leading to significant costs. Moreover, the requirement that labels cannot be updated by merely marking the change, modifying the adhesive label, or affixing a new adhesive label over the old one necessitates that products (such as those in aluminum sacks) be unpacked and then repacked, which in turn raises occupational safety concerns about the repeated exposure of workers to these products during the process.
Further complicating matters are sporadic announcements from the government regarding changes in the use pattern or cautionary notes about individual products, as these necessitate re-approval of the label if any license has been submitted for renewal or amendment. This requirement wastes resources and results in additional costs, including the destruction of existing inventory labels and the labor-intensive process of unpacking and repacking recalled products.
Recommendations:
- Fast-track revisions to Article 14 of the Agro-pesticides Management Act. Since 2019, the Committee has been calling for amendments, such as removal of the mandate to recall products within six months due to minor label amendments that do not affect safety or manufacturing, but has yet to see any substantial action or even receive a formal reply. We urge the Animal and Plant Health Inspection Agency (APHIA) to confirm that our proposed amendment to Article 14 is among the prospective revisions. Furthermore, we urge APHIA to accelerate the drafting process, enabling a bill to be submitted for legislative approval without further delay.
- Add a positive list in the Enforcement Rules of the Agro-pesticides Management Act specifying the types of changes that do not require relabeling. Changes such as the name of the manufacturer, extension of product shelf life, and modifications to packaging, labeling design, and barcodes have no impact on product safety. The practice of allowing such modifications without relabeling is already common in other industries. To avoid unnecessary costs and waste, and in consideration of industry practice, the sale of products should be allowed to continue until their expiry dates.
Suggestion 2: Expedite the review process for new active ingredients and products with new content or new formulations.
Under APHIA’s 10-year plan to reduce the volume of chemical pesticide usage by half, companies are encouraged to register pesticides with high safety, low dosage, and specificity to reduce the risks of pesticide exposure to farmers, as well as to mitigate negative environmental impact. Achieving that goal will require the approval of products with new active ingredients and new formulations.
Whether for pesticide registration, renewal, or re-registration, however, the proportion of application approvals for new active ingredients and new formulation products has been minimal. Statistics compiled by APHIA’s Agricultural Information Network show that of the 229 certificates issued in 2023, only 3 were for new active ingredients. In 2022, 296 certificates were issued, with a mere 9 dedicated to new active ingredients. Additionally, on the list of active ingredients that have passed the 15-year pesticide re-registration, 20 active ingredients were approved in 2023, much fewer than the 34 approved in 2022.
We urge APHIA to prioritize the allocation of its review and administrative capacities toward innovative products, such as those with new active ingredients and new formulations. This prioritization would spur the launch of innovative products and aid the elimination of high-hazard or high-risk formulation products.
Suggestion 3: Accelerate the administrative process for determining the maximum residue limits for pesticides.
We are grateful to the TFDA and the MOHW for their commendable efforts in increasing the frequency of announcements regarding the maximum residue limits (MRLs) of pesticides. The TFDA has consistently issued official announcements on MRLs at least three times annually, a practice that greatly benefits stakeholders by providing clearer regulatory guidance.
Despite these improvements, several aspects of the administrative procedures for pesticide registration remain unclear. These ambiguities have caused delays in the registration process, significantly impacting applicants who have made substantial investments in Taiwan. Uncertainty regarding the following points has made it challenging for applicants to predict the approval timeline for their applications:
- The timeline for sending cases to APHIA to schedule review by the Pesticide Advisory Committee under the MOA after the cases have passed review by the Agricultural Chemicals Research Institute.
- The timeline for sending cases to the TFDA after they have passed the Pesticide Advisory Committee’s review.
- The timeline for arranging document reviews by experts and comprehensive review by the Food Sanitation, Safety and Nutrition Advisory Committee after the TFDA has received a case.
- Following case reviews, the various required administrative procedures and joint actions involving some 20 functional offices or units. These procedures may take more than one month, not including the time required for subsequent pre-notification and official announcement of related regulations, which may take at least another four months.
- APHIA’s informal pre-notification procedure that, although officially optional, is being enforced as if mandatory. Completing this process can take up to two months. APHIA has advised the Committee that applicants are expected to initiate direct communication with the TFDA, requesting that it notify APHIA about the contents of any forthcoming announcement prior to its public disclosure. In practice, this procedure significantly delays APHIA’s ability to announce the approved use pattern of registration after the TFDA discloses the finalized MRLs. This extended timeline for procedural compliance not only complicates the registration process but also affects the timely introduction and use of registered products, hindering the efficient management and implementation of agricultural practices.
- The requirement that companies await an official announcement from APHIA before proceeding with applications for permits or changes in labeling. This administrative procedure alone can take at least one month.
We urge departments within the MOA and the MOHW to establish and clearly define the procedures and precise timings of administrative processes at both the ministerial and departmental levels. Clarifying these procedures would help streamline the administrative process to the benefit of all stakeholders.
Additionally, we ask that these procedural details be made available to the public. Such transparency could significantly enhance horizontal communication across different ministries and departments, leading to a more coordinated and efficient administrative process.
Suggestion 4: Reassess the reasonableness of data requirements for registering generic pesticides to ensure safe and effective use by farmers.
The Committee has raised this issue in the past four White Paper issues, but no progress has been made. Compared to the regulatory frameworks in other countries for registering generic agricultural products, the procedure in Taiwan stands out for its conciseness, requiring only the submission of physical and chemical data. This approach focuses on ensuring that the active ingredients and formulation type of the generic product match those of the originally registered product.
However, other ingredients in the product may differ from what was covered in the original comprehensively evaluated registration. This discrepancy in composition raises concerns about the efficacy of the generic products, as it cannot be guaranteed to fully match that of the original products. As a result, farmers may inadvertently overuse these products or use them in ways that deviate from the government’s pesticide reduction policy.
Recommendations:
- Revise current legislation to mandate at least one field test assessing the efficacy of generic pesticides on the crops for which registration is sought.
- Require the submission of comprehensive toxicological data for the registration of generic products. Data should include reports on oral-, dermal-, and inhalation-acute toxicity, as well as eye irritation tests, to unequivocally demonstrate the safety of the generic products for users.
- Formalize the registration process for generic pesticides. This process should include evaluation by the MOA’s Pesticide Advisory Committee for the generic product’s necessity, efficacy, and safety before approval is granted. Such measures will ensure that generic pesticides introduced into the market meet the expected high standards of performance and safety, thereby protecting users and supporting the goals of pesticide reduction and sustainable agriculture practices.
Suggestion 5: Set up a transparent regulatory frame-work with a predictable timeline and adopt a product-based regulatory approach harmonized with Taiwan’s major trading partners for genome-edited products.
Agricultural innovation has played an essential role in increasing yields and productivity in support of growing, prosperous civilizations. Moreover, considering the rapidly growing world population, climate change, and increasing scarcity of natural resources such as arable land and water, progress in plant propagation has gained unprecedented importance.
High-yielding crops of superior nutritional value that can be grown more resource-efficiently are increasingly becoming the cornerstone of sustainable yet highly productive agriculture. In addition, there is a need to make crops more pest- and disease-resistant as well as more tolerant to adverse conditions such as drought, heat, submergence, and salinity. Innovations in precision biotechnology, such as gene editing, are therefore required to enhance the speed, predictability, precision, and success rate of plant breeding.
As highlighted in the 2023 White Paper, the World Trade Organization released the joint International Statement on Agricultural Applications of Precision Biotechnology, supported by 10 members, urging governments to implement science-based and globally harmonized policies for precision biotechnology. To support agricultural innovation, many of Taiwan’s key trading partners – including Argentina, Australia, Brazil, India, Japan, the Philippines, and the United States – have since implemented well-functioning and proportionate regulatory systems. These markets have exemptions granted certain types of gene-edited crops from their GMO regulations. Furthermore, the exemption by some government agencies can be evaluated and confirmed through a pre-consultation mechanism.
Over the past 12 months, some countries and regions have made further noteworthy progress in developing policies for the management of genome-edited products. For example, the European Commission released its New Genomic Techniques (NGT) proposal for new regulation on plants produced by certain new genomic techniques (for example, gene-editing technology) on July 5, 2023. The Commission also proposed that Category 1 NGT plants should be exempted from the requirements of GMO legislation, affirming the Commission’s position that plants derived from these technologies have safety profiles comparable to conventional counterparts and may contribute to sustainable agriculture and the European Union’s Farm to Fork Strategy, as concluded in the NGT study published on April 29, 2021.
On December 20, 2023, the Singapore Food Agency released a policy document for public consultation on the regulatory framework for genome-edited crops for food and feed. This document proposed that plants that do not contain foreign DNA should be exempted from pre-market safety assessment. On January 18, 2024, Thailand’s Technical Biosafety Committee approved the Guidelines for Consideration of Genome Editing, stipulating that products lacking novel genetic combinations or foreign genetic sequences should be exempt from GMO regulation.
These recent policy developments have demonstrated the importance of precision biotechnology such as gene editing to address challenges in agricultural production as well as to support food sufficiency and achieve sustainability goals.
Taiwan is a key global trading partner for agricultural products, including seed and plant products. To help Taiwan maintain a competitive and secure food and feed supply, we urge the government to establish a transparent regulatory framework with predictable timelines and adopt a product-based regulatory approach for gene-edited products to ensure harmonization with Taiwan’s major trading partners.
農化委員會非常感謝衛生福利部食品藥物管理署及農業部的支持並重視本委員會所提出的建議。為因應氣候變遷及維持糧食安全等需求,祈請各主管機關能考量以下建言,持續精進相關管理政策,以期能加速引進高安全性、高效率且用量少的新型農藥產品及有助育種創新的新技術,得以減少環境危害並促進農業環境永續發展,進一步加快農藥管理法修訂進度。
建議一:加速修訂《農藥管理法》第14條及相關規定
本委員會自2019年起不斷提出本項訴求,迄今未觀察到任何實質性作為。《農藥管理法》第14條第1項及相關子法《農藥標示管理辦法》明列:標示經核准後「原標示應於六個月內更換之」,對於可能影響產品安全性的變更,這樣的要求是合理的;但若不影響農民使用安全之內容,已上市產品則應無需撤回重新貼標。
標示核准變更後,市售產品回收或更換標示程序繁瑣及困難,造成大幅增加額外處理成本。此外,法規明訂「更換之標示,不得以塗改、貼紙修正、重複黏貼方式為之」,部分產品標示需要整個拆除包裝後再重新分裝(例如鋁袋),增加作業人員重複暴露這類產品的職業衛生安全疑慮。
另外,主管機關對於個別產品的登記使用範圍或注意事項等變更的零星公告,導致辦理許可證登記相關事項時,將強制依最新公告內容要求進行標示修正,已造成資源的浪費及額外成本,例如:銷毀已印製之原核准標示、回收及重新分裝市場上尚未銷售完畢之產品等。
【建議 】
- 請加速修訂《農藥管理法》第14條及相關規定。本委員會自2019年起不斷提出進行相關法規修訂,例如:希望取消六個月內召回未符合實際製造工廠或無關安全疑慮之些微標示修改的限制,卻未觀察到任何實質性作為或正式答覆。敦請農業部動植物防疫檢疫署 研議本委員對於該法14條提出之建議內容,加速修訂草案,盡快將其提送至立法院進行審議及批准。
- 建議於農藥標示管理辦法中增訂正面表列以明訂不需進行回收或更換標示事項,例如:變更國外生產工廠、變更標示有效期間、修改包材設計或條碼變更等無關產品安全性等標示變更內容。標示修改後不進行回收並重新標示之作法,已在其他行業類別中行之有年,為避免不必要的資源浪費及成本,並考量產業慣例,應允許前述無關產品使用安全性之樣態,原市售產品標示可允用及販售,直至該批產品效期為止。
建議二:加速新有效成分、新劑型產品之審查登記
因應農業部動植物防疫檢疫署「化學農藥十年減半行動方案」,主管機關鼓勵業者登記安全性高、用量少、具專一性農藥,以降低農民用藥暴露及環境影響風險,建請將主要審查與行政量能投入在於新有效成分、新劑型含量等創新產品,以加速該類產品加速上市以汰換高危害或是高風險之成品農藥。
農藥登記、展延、重新評估,審查類型種類繁多,但主管機關對新有效成分及新劑型產品之審查通過占比相當微量。依農藥資訊服務網公開資訊統計,2023年成品農藥進口證與製造證共發證229張,其中僅3張屬於新有效成分;2022年成品農藥進口證與製造證共發證296張,其中僅9張屬於新有效成分。另外參考登記屆滿15年農藥有效成分審查通過清單,2023年通過20個有效成分,2022年通過34個有效成分。
【建議 】
建請農委會加速對新有效成分、新劑型產品之審查與核可,有助於汰換高風險之產品。
建議三:加速農藥殘留容許量訂定之行政程序
感謝食藥署及衛福部近年已改善農藥殘留容許量標準 (以下簡稱容許量)公告頻度,目前已可觀察到每年至少3次容許量之正式公告,使各相關產業有明確的法源依據而受益匪淺。雖已觀察到公告頻度的改善,但農藥登記的程序中仍有諸多不明確之行政流程,導致延宕產品登記及影響申請人投資意願,以下幾點之不確定性造成申請人難以預測登記的核准時間:
- 案件經農業部農業藥物試驗所審畢後,提送農業部動植物防疫檢疫署(以下簡稱防檢署)進行農藥技術諮議會(以下簡稱農藥諮議會)排程之所需時間。
- 案件審查通過農藥諮議會後提送食藥署之所需時間。
- 案件進入食藥署後安排專家書審及會議審查所需時間。
- 資料審查完畢後,仍須耗費大量行政程序及時間會辦至少20多個組室或單位,耗費1個月以上的時間,且不包括後續預告、公告之法制作業至少4個月的時間。
- 防檢署強制執行非法制程序的「預先通知公告」流程需耗時至少兩個月,先前多次於白皮書中回覆申請人應自行與食藥署溝通,並請食藥署公告前先行副知防檢署該公告作業內容。因此,即使食藥署已公告訂定農藥殘留容許量,此程序已造成防檢署嚴重延遲公告核准使用方法與增加流程複雜性,並影響新產品的及時引進及使用,影響農業生產管理之作業。
- 申請人須待防檢署正式公告後才能辦理後續許可證請領或是進行標示變更等需額外耗費月餘的多項行政作業。
【建議 】
建請農業部及衛生福利部轄下各機關明確訂定部會間及部會內所需之各項行政程序及所需時程並公諸於眾。澄清這些程序將有助於簡化行政流程,使產、官雙方受益;此外,我們希望相關程序可以公開透明化,各部會間可以改善或加強跨部會之橫向溝通,增加協調性及提高行政效率。
建議四:正視農藥學名藥(成品)要求登記的合理性,以確保農民用藥之安全性及有效性
委員會已第四年提出此議題,至今尚未觀察到農藥主管機關對於學名藥成品有任何精進管制作為。
綜觀其他各國之學名藥登記,僅有台灣對於學名藥登記之資料要求最簡要(僅需繳交物理及化學數據資料),這種作法僅確認學名藥有效成分、劑型與原廠藥劑相同。然而,其他成分皆與最初、受充分審查之原廠藥劑不同。這種成分上的差異,引起了藥效以及產品安全上的擔憂,因為配方不能確認與原廠產品完全匹配。因此,易造成農民可能會無意中過度使用這些產品,並悖離農藥減量政策。
故,委員會建議主管機關修法:
- 學名藥應於擬登記作物至少進行一場次藥效藥害田間試驗以利評估藥效
- 學名藥產品須提交毒理報告(口服、皮膚、呼吸急毒性與眼刺激性試驗資料),以證明該學名藥劑之安全性,並維護使用者之安全。
- 委員會也建議,關於學名藥查驗登記,應屬正規登記流程,該正規程序應包括諮議會審議批准之前對其必要性、防治效果及安全性進行評估。此類措施將確保引入市場的學名藥符合預期高標準的藥效以及安全性,從而保護使用者並支持農藥減少和永續農業實踐的目標。
建議五:敦促主管機關針對基因編輯產品建立透明的監管架構和可預期的時程,並採取與貿易夥伴一致、依產品為導向的監管方式
農業創新在提高產量和生產力上發揮了至關重要的作用,進而得以支持日益繁榮的文明。此外,鑑於世界人口的迅速增長、氣候變遷以及可耕地和水等自然資源的日益稀缺,植物育種的進展更是前所未有的重要。產量高、營養價值提升且資源利用效率更佳的作物日漸成為永續又高產量之農業的基石。再者,作物需要更能夠抵抗病蟲害,並對逆境如乾旱、高溫、淹水和鹽害等不利的種植條件更具耐受性。因此,需要基因編輯等精準生物技術之創新來提升植物育種的速度、可預測性、精確性和成功率。
如2023年白皮書中所強調的,世界貿易組織(WTO)於2018年發布由十個會員國共同簽署的《國際精準生物技術農業應用聲明(International Statement on Agricultural Applications of Precision Biotechnology)》,該聲明敦促各國政府實施基於科學且全球調和的精準生物技術相關政策。為了支持農業創新,許多台灣的主要貿易夥伴,包括美國、日本、澳洲、阿根廷、巴西、菲律賓和印度均已經訂定實施運作良好且合宜的監管制度,並將特定類型的基因編輯產品從基因改造的管理範疇中排除。政府主管機關可經由預先諮商的方式,根據產品的特性進行評估,來確認其是否符合豁免範疇。
在過去的12個月中,部分地區和國家對基因編輯產品管理政策制定取得了顯著的進展。舉例來說,歐盟執委會於2023年7月5日發布了新基因體技術(New Genomic Techniques, NGT)提案,對利用新基因體技術(例如基因編輯技術)開發的植物提出新的法規,並提議第一類NGT植物可從基因改造生物法條的要求中豁免排除,據此確認歐盟執委會的立場,認同源自這些技術的植物具有與傳統植物相當的安全性,並且能有助於歐盟主張的「從農場到餐桌策略」和環境永續性,其與2021年4月29日歐盟執委會發布的NGT研究所得到的結論一致。
2023年12月20日,新加坡食品局提出一份政策文件,就食品和飼料用基因編輯作物的監管架構進行公眾諮商,這份文件提議,不含外源DNA的植物可免除上市前的安全評估。此外,2024年1月18日,泰國的技術性生物安全委員會(Technical Biosafety Committee)核准其「基因編輯技術研發生物之評估指引(Guideline for Determination of Organisms Developed by Genome Editing Technology)」,認定不含新穎基因組合或外源基因序列的產品可免除基因改造法規的監管。最近的這些政策發展都證明精準生物技術(如基因編輯)對於解決農業生產挑戰以及支持糧食自給自足和實現永續發展目標的重要性。
台灣身為農產品(包括種子/植物產品)上重要的全球貿易夥伴,為了協助台灣維持競爭力並確保充足的糧食和飼料原料供應,我們敦促食品藥物管理署和農業部能對基因編輯產品建立透明的監管架構和可預期的時程,並採取與台灣主要貿易夥伴一致、依產品為導向的監管方式。
